SCHEMBL5362826

SCHEMBL5362826

N#Cc1c(F)c(F)cc(C(=O)Cl)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
TRPV4 Q9HBA0 1/20 0.36
CES2 O00748 2/20 0.35
CES1 P23141 2/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
STAT3 P40763 3/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA4 P22748 2/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
NOTUM Q6P988 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HPGD P15428 1/20 0.31
ENPP2 Q13822 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364750 0.86 TRPV4 (0.38) ALDH1A1TRPV4CES2CES1TAS1R3
SCHEMBL3552234 0.85 KEAP1 (0.39) TRPV4CES2CES1STAT3MAOA
SCHEMBL14408161 0.83 STAT3 (0.36) ALDH1A1ALOX15TRPV4CES2CES1
SCHEMBL7044003 0.83 DGAT1 (0.38) ALDH1A1TRPV4CES2CES1TAS1R3
SCHEMBL7045129 0.80 ALDH1A1 (0.48) ALDH1A1STAT3CA1CA2KDM4E
SCHEMBL5360639 0.78 ALDH1A1 (0.37) ALDH1A1ALOX15TRPV4TAS1R3TAS1R1
SCHEMBL809118 0.76 TRPV4 (0.50) TRPV4CES2CES1STAT3CA1
SCHEMBL3552211 0.75 STAT3 (0.56) ALDH1A1ALOX15STAT3KDM4E
SCHEMBL345016 0.74 ALDH1A1 (0.48) ALDH1A1ALOX15CES2CES1CA1
SCHEMBL8006776 0.73 TRPV4 (0.47) ALDH1A1ALOX15TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7268248-B2 Bichlorinated compounds formed under with carboxy groupand elimation of water BAYER AKTIENGESELLSCHAFT (DE) 2007-09-11 US claimed
US-20040167350-A1 Bichlorinated compounds formed under with carboxy groupand elimation of water MARHOLD ALBRECHT (DE) 2004-08-26 US claimed
US-20030092929-A1 Using halogenated xylene compound; chemical intermediate for quinolone antibiotics MARHOLD ALBRECHT (DE) 2003-05-15 US claimed
EP-1215202-A1 Intermediates for the preparation of possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives BAYER AG (DE) 2002-06-19 EP claimed
EP-0977729-B1 3-CYANO-2,4,5-TRIFLUORO-BENZOYL FLUORIDE AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BAYER AG (DE) 2002-03-13 EP claimed
US-20010023300-A1 Preparing by reacting 3-cyano-2,4-dichloro-4-fluoro-benzoyl chloride nucleophilically with a fluoridizing agent; forming 3-cyano-2,4,5-trifluoro-benzoyl chloride from title compound; intermediates to antiinfective quinolonecarboxylic acids MARHOLD ALBRECHT (DE) 2001-09-20 US claimed
US-6278013-B1 AS CHEMICAL INTERMEDIATES FOR PREPARING QUINOLINECARBOXYLIC ACID DERIVATIVE ANTIBIOTICS USED IN VETERINARY MEDICINE BAYER AKTIENGESELLSCHAFT (DE) 2001-08-21 US claimed
EP-0977729-A1 3-CYANO-2,4,5-TRIFLUORO-BENZOYL FLUORIDE AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BAYER AG (DE) 2000-02-09 EP claimed
WO-1998047862-A1 3-CYANO-2,4,5-TRIFLUORO-BENZOYL FLUORIDE AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BAYER AKTIENGESELLSCHAFT (DE) 1998-10-29 WO claimed
CN-111377826-B Green synthesis process of key intermediate of quinolone 浙江本立科技股份有限公司 2021-03-02 CN disclosed
CN-111377826-A Green synthesis process of key intermediate of quinolone 浙江本立科技股份有限公司 2020-07-07 CN disclosed
US-7268248-B2 Bichlorinated compounds formed under with carboxy groupand elimation of water BAYER AKTIENGESELLSCHAFT (DE) 2007-09-11 US disclosed
US-7268248-B2 Bichlorinated compounds formed under with carboxy groupand elimation of water BAYER AKTIENGESELLSCHAFT (DE) 2007-09-11 US disclosed
US-7268248-B2 Bichlorinated compounds formed under with carboxy groupand elimation of water BAYER AKTIENGESELLSCHAFT (DE) 2007-09-11 US disclosed
EP-0944385-A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO 3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING $i(HELICOBACTER PYLORI) INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH BAYER AG (DE) 1999-09-29 EP disclosed
EP-0882049-A1 POSSIBLY SUBSTITUTED 8-CYANO-1-CYCLOPROPYL-7-(2,8-DIAZABICYCLO- 4.3.0]-NONAN-8-YL)-6-FLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLIN CARBOXYLIC ACIDS AND THEIR DERIVATIVES BAYER AG (DE) 1998-12-09 EP disclosed
WO-1998047862-A1 3-CYANO-2,4,5-TRIFLUORO-BENZOYL FLUORIDE AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF BAYER AKTIENGESELLSCHAFT (DE) 1998-10-29 WO disclosed
WO-1998026779-A1 THE USE OF 7-(2-OXA-5,8-DIAZABICYCLO[4.3.0]NON-8-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDON CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF HELICOBACTER PYLORI INFECTIONS AND ASSOCIATED GASTRODUODENAL DISEASES BAYER AKTIENGESELLSCHAFT (DE) 1998-06-25 WO disclosed
WO-1998026768-A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO[3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING HELICOBACTER PYLORI INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH BAYER AKTIENGESELLSCHAFT (DE) 1998-06-25 WO disclosed
WO-1997031001-A1 POSSIBLY SUBSTITUTED 8-CYANO-1-CYCLOPROPYL-7-(2,8-DIAZABICYCLO-[4.3.0]-NONAN-8-YL)-6-FLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLIN CARBOXYLIC ACIDS AND THEIR DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1997-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167350-A1 Bichlorinated compounds formed under with carboxy groupand elimation of water CLIC4, AFF4, CBR1 ALDH1A1 407/4885ALOX15 1016/4885TRPV4 545/4885
US-20010023300-A1 Preparing by reacting 3-cyano-2,4-dichloro-4-fluoro-benzoyl chloride nucleophilically with a fluoridizing agent; forming 3-cyano-2,4,5-trifluoro-benzoyl chloride from title compound; intermediates to antiinfective quinolonecarboxylic acids CLIC4, AFF4, CBR1 ALDH1A1 1360/4885ALOX15 768/4885TRPV4 915/4885
US-20030092929-A1 Using halogenated xylene compound; chemical intermediate for quinolone antibiotics CLIC4, FLI1, AFF4 ALDH1A1 1343/4885ALOX15 2100/4885TRPV4 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.